{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T19:17:40Z","timestamp":1726514260716},"reference-count":32,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.vaccine.2016.01.015","type":"journal-article","created":{"date-parts":[[2016,1,19]],"date-time":"2016-01-19T17:43:55Z","timestamp":1453225435000},"page":"1208-1214","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Evaluation of measles\u2013rubella vaccination for mothers in early puerperal phase"],"prefix":"10.1016","volume":"34","author":[{"given":"Michi","family":"Hisano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuo","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eisuke","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruhiko","family":"Sago","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koushi","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"unstructured":"World Health Organization Western Pacific Region, Brunei Darussalam, Cambodia, Japan verified as achieving measles elimination, http:\/\/www.wpro.who.int\/mediacentre\/releases\/2015\/20150327\/en\/ (accessed on 8\/28\/2015).","key":"10.1016\/j.vaccine.2016.01.015_bib0165"},{"key":"10.1016\/j.vaccine.2016.01.015_bib0170","first-page":"117","article-title":"Rubella and congenital rubella syndrome in Japan, as of June 2015","volume":"36","author":"National Institute of Infectious Diseases (Japan)","year":"2015","journal-title":"IASR"},{"key":"10.1016\/j.vaccine.2016.01.015_bib0175","first-page":"457","article-title":"Nationwide Rubella Epidemic\u2014Japan, 2013","volume":"62","author":"Centers for Disease Control and Prevention","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2016.01.015_bib0180","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.1016\/j.vaccine.2014.06.022","article-title":"Recent progress and concerns regarding the Japanese immunization program: addressing the \u201cvaccine gap\u201d","volume":"32","author":"Saitoh","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.01.015_bib0185","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1016\/j.vaccine.2013.03.012","article-title":"Changes in the prevalence of the measles, rubella, varicella-zoster, and mumps virus antibody titers in Japanese pregnant women","volume":"31","author":"Hanaoka","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.01.015_bib0190","doi-asserted-by":"crossref","first-page":"4752","DOI":"10.1016\/j.vaccine.2012.04.026","article-title":"Current issues with the immunization program in Japan: can we fill the \u201cvaccine gap\u201d?","volume":"30","author":"Saitoh","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.01.015_bib0195","first-page":"1117","article-title":"Notice to readers: revised ACIP recommendation for avoiding pregnancy after receiving a rubella-containing vaccine","volume":"50","author":"Centers for Disease Control and Prevention","year":"2001","journal-title":"MMWR Morb Mortal Wkly Rep"},{"unstructured":"World Health Organization. Prevention of congenital rubella syndrome (CRS). In: Standards for maternal and neonatal care, http:\/\/apps.who.int\/iris\/bitstream\/10665\/69735\/1\/a91272.pdf (accessed on 10\/29\/2015).","key":"10.1016\/j.vaccine.2016.01.015_bib0200"},{"key":"10.1016\/j.vaccine.2016.01.015_bib0205","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/jmv.1890300402","article-title":"Detection of measles virus genomic sequences in SSPE brain tissue by the polymerase chain reaction","volume":"30","author":"Godec","year":"1990","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2016.01.015_bib0210","first-page":"1","article-title":"General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"55","author":"Kroger","year":"2006","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.vaccine.2016.01.015_bib0215","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/j.vaccine.2015.02.043","article-title":"Rubella susceptibility in pregnant women and results of a postpartum immunization strategy in Catalonia, Spain","volume":"33","author":"Vilajeliu","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2016.01.015_bib0220","first-page":"1","article-title":"Prevention of pertussis, tetanus, and diphtheria among pregnant and postpartum women and their infants recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"57","author":"Murphy","year":"2008","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.vaccine.2016.01.015_bib0225","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1093\/cid\/cir538","article-title":"Kinetics of the antibody response to tetanus-diphtheria-acellular pertussis vaccine in women of childbearing age and postpartum women","volume":"53","author":"Halperin","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2016.01.015_bib0230","first-page":"1424","volume":"60","author":"Centers for Disease Control and Prevention","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2016.01.015_bib0235","first-page":"131","article-title":"Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women \u2013 Advisory Committee on Immunization Practices (ACIP), 2012","volume":"62","author":"Centers for Disease Control and Prevention","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2016.01.015_bib0240","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/infdis\/145.2.661","article-title":"Effect of immunization against rubella on lactation products. II. Maternal-neonatal interactions","volume":"145","author":"Losonsky","year":"1982","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2016.01.015_bib0245","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S0022-3476(80)80264-2","article-title":"Neonatal rubella in a breast-fed infant after postpartum maternal infection","volume":"97","author":"Klein","year":"1980","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2016.01.015_bib0250","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/0002-9343(93)90360-2","article-title":"Prolactin and immunomodulation","volume":"95","author":"Reber","year":"1993","journal-title":"Am J Med"},{"key":"10.1016\/j.vaccine.2016.01.015_bib0255","doi-asserted-by":"crossref","first-page":"A465","DOI":"10.1016\/j.autrev.2011.11.009","article-title":"Prolactin and autoimmunity","volume":"11","author":"Shelly","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.vaccine.2016.01.015_bib0260","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s12016-009-8185-3","article-title":"Prolactin and autoimmunity","volume":"40","author":"Jara","year":"2011","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.vaccine.2016.01.015_bib0265","first-page":"2216","article-title":"Elevated bioactive prolactin levels in systemic lupus erythematosus\u2014association with disease activity","volume":"28","author":"Pacilio","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1016\/j.vaccine.2016.01.015_bib0270","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1191\/096120301701549688","article-title":"Enhanced serum prolactin (PRL) in patients with systemic lupus erythematosus: PRL levels are related to the disease activity","volume":"10","author":"Jacobi","year":"2001","journal-title":"Lupus"},{"key":"10.1016\/j.vaccine.2016.01.015_bib0275","first-page":"1514","article-title":"Elevated serum bioactive prolactin concentrations in patients with systemic lupus erythematosus are associated with disease activity as disclosed by homologous receptor bioassays","volume":"34","author":"C\u00e1rdenas-Mondrag\u00f3n","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.vaccine.2016.01.015_bib0280","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1093\/rheumatology\/36.4.426","article-title":"High prolactin and low dehydroepiandrosterone sulphate serum levels in patients with severe systemic sclerosis","volume":"36","author":"Straub","year":"1997","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.vaccine.2016.01.015_bib0285","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1196\/annals.1351.023","article-title":"Androgen and prolactin (Prl) levels in systemic sclerosis (SSc): relationship to disease severity","volume":"1069","author":"Mirone","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.vaccine.2016.01.015_bib0290","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.cell.2006.12.036","article-title":"A cathepsin D-cleaved 16kDa form of prolactin mediates postpartum cardiomyopathy","volume":"128","author":"Hilfiker-Kleiner","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2016.01.015_bib0295","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1161\/CIRCULATIONAHA.109.901496","article-title":"Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study","volume":"121","author":"Sliwa","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.vaccine.2016.01.015_bib0300","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/icb.2008.29","article-title":"Prolactin can modulate CD4+ T-cell response through receptor-mediated alterations in the expression of T-bet","volume":"86","author":"Tomio","year":"2008","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.vaccine.2016.01.015_bib0305","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1600-0897.2010.00852.x","article-title":"Th1\/Th2\/Th17 and regulatory T-cell paradigm in pregnancy","volume":"63","author":"Saito","year":"2010","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.vaccine.2016.01.015_bib0310","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/humrep\/deg156","article-title":"Increased T helper 1 cytokine responses by circulating T cells are present in women with recurrent pregnancy losses and in infertile women with multiple implantation failures after IVF","volume":"18","author":"Kwak-Kim","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.vaccine.2016.01.015_bib0315","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1034\/j.1600-0897.2002.01105.x","article-title":"Expression of intracellular Th1 and Th2 cytokines in women with recurrent spontaneous abortion, implantation failures after IVF\/ET or normal pregnancy","volume":"48","author":"Ng","year":"2002","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.vaccine.2016.01.015_bib0320","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1002\/jmv.21620","article-title":"Relationship of Th1\/Th2 cell balance with the immune response to influenza vaccine during pregnancy","volume":"81","author":"Yamaguchi","year":"2009","journal-title":"J Med Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16000414?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X16000414?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,16]],"date-time":"2018-09-16T03:52:43Z","timestamp":1537069963000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X16000414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S0264410X16000414"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.01.015","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of measles\u2013rubella vaccination for mothers in early puerperal phase","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2016.01.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}